American Century Companies’s SpringWorks Therapeutics SWTX Stock Holding History

American Century Companies’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,907	Closed	-$231K	–	2878
2025 Q2	$231K	Buy	+4,907	New	+$218K	﹤0.01%	2714
2024 Q3	–	Sell	-7,733	Closed	-$291K	–	2956
2024 Q2	$291K	Sell	7,733 -2,032	-21%	-$85.5K	﹤0.01%	2640
2024 Q1	$481K	Buy	9,765 +3,059	+46%	+$141K	﹤0.01%	2463
2023 Q4	$245K	Buy	+6,706	New	+$175K	﹤0.01%	2632
2023 Q2	–	Sell	-10,709	Closed	-$164K	–	2840
2023 Q1	$164K	Buy	+10,709	New	+$313K	﹤0.01%	2463

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

American Century Companies's SWTX Position: Q3 2025 in Review

American Century Companies sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 4,907 shares — an estimated $231K sold.

American Century Companies first reported a position in SWTX in Q1 2023 and held it in 5 quarters. The position peaked at $481K in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

American Century Companies reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
American Century Companies sold 4,907 SpringWorks Therapeutics shares in Q3 2025, an estimated $231K.
American Century Companies first reported a position in SpringWorks Therapeutics in Q1 2023 and held it in 5 quarters.
American Century Companies's SpringWorks Therapeutics position peaked at $481K in Q1 2024.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on American Century Companies's 13F filing for Q3 2025, filed 12 Nov 2025.